Gastric cancer (GC) is a prevalent and devastating disease with poor prognosis.
Lack of biomarkers for early detection and effective targeted therapeutics for GC patients represent two major challenges for this disease.
Through iTRAQ-LC-MS/MS phosphoproteomics analysis of 14 GC
